LY 377604
Alternative Names: LY377604Latest Information Update: 07 Feb 2014
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Beta 2 adrenergic receptor antagonists; Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus
- Discontinued Obesity
Most Recent Events
- 07 Feb 2014 Discontinued - Phase-II for Obesity in USA (PO)
- 03 Apr 2000 Preclinical development for Diabetes mellitus in USA (PO)
- 03 Apr 2000 Preclinical development for Obesity in USA (PO)